| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 341.60B | — |
| Operating expense | — | — |
| Net income | 116.30B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CHGCY returned +1.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -17.1% |
| 1 year | +1.6% |
| 5 years | +14.4% |
| 10 years | +302.0% |
| All-time high | $33.61 (Feb 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CHGCY would be worth today ›No. Chugai Pharmaceutical Co., Ltd. has not paid a dividend in the past 12 months.
Chugai Pharmaceutical Co., Ltd. is part of the Healthcare sector.
Chugai Pharmaceutical Co., Ltd. has a market cap of 71.65B USD, based on the latest quote.
Chugai Pharmaceutical Co., Ltd. is scheduled to report earnings on Oct 27, 2026.
